Key facts
- Prosecutors allege Ge led the scheme with Samy Khouadja and Eamma Safi, trading on confidential tips from 2016 to 2024.
- Nine individuals in total were charged in the alleged insider trading network, the Justice Department said.
- Prosecutors say tips preceded deals including AstraZeneca's 2020 planned $39 billion acquisition of Alexion Pharmaceuticals.
- Charging papers cite a 2019 message from Ge seeking introductions to investment bankers working on M&A.
- Prosecutors allege the defendants used burner phones, encrypted apps and code words such as "greens" for money.
- Ge is scheduled to be arraigned in federal court on December 16, 2026.
Zhi Ge, 35, made his initial appearance in federal court in Boston on November 20, 2026, after being extradited from Singapore to face securities fraud and money laundering charges, the US Department of Justice said. He was arrested in his home country in 2024, and a court in Singapore recently ordered his extradition. He is scheduled to appear again on December 16 for an arraignment. His attorney did not immediately respond to a request for comment.
Ge is one of nine individuals charged over what prosecutors allege was a years-long insider trading scheme relying on tips from investment bankers and other corporate insiders. Prosecutors say Ge led the network with Samy Khouadja, a former investment banker in France, and Eamma Safi, who co-owned a French restaurant with Khouadja. The US considers most of the defendants, including Khouadja, fugitives. A lawyer for Khouadja did not immediately respond to a request for comment. Safi, in US custody since 2025, has pleaded not guilty.
Prosecutors allege the three recruited bankers and others from 2016 to 2024 to supply inside information about publicly traded companies and paid insiders for tips. Charging papers say Ge tried to recruit additional insiders and cite 2019 messages in which he asked an actor friend in New York to introduce him to "investment bankers in big banks working in M&A specifically."
The indictment said the tips let them trade ahead of announcements including AstraZeneca's 2020 planned $39 billion acquisition of Alexion Pharmaceuticals and Novartis's 2024 acquisition of MorphoSys for $2.9 billion. Prosecutors said the defendants used burner cell phones and encrypted messaging apps, spoke in code, calling money "greens" and prospective merger partners "girls" and "models," and leaked information to journalists to profit once the news became public.